Mebendazole as a Candidate for Drug Repurposing in Oncology: …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769799/
WEBAug 31, 2019 · Mebendazole was more potent as an antiproliferative agent against gastric cancer cell lines (IC50 0.39–1.25 μM) than several other clinically approved chemotherapic agents tested such as 5-fluorouracil (5-FU), oxaliplatin, gemcitabine, … Author: Andrea Emanuele Guerini, Luca Triggiani, Marta Maddalo, Marco Lorenzo Bonù, Francesco Frassine, Anna... DOI: 10.3390/cancers11091284 Publish Year: 2019 Publication: Cancers (Basel). 2019 Sep; 11(9): 1284.
Author: Andrea Emanuele Guerini, Luca Triggiani, Marta Maddalo, Marco Lorenzo Bonù, Francesco Frassine, Anna...
DOI: 10.3390/cancers11091284
Publish Year: 2019
Publication: Cancers (Basel). 2019 Sep; 11(9): 1284.
DA: 20 PA: 47 MOZ Rank: 2